Aytu BioPharma

Aytu BioPharma is a specialty pharmaceutical company focused on developing and commercializing innovative medicines for complex central nervous system (CNS) diseases. The company's primary therapeutic areas are major depressive disorder (MDD) and attention deficit/hyperactivity disorder (ADHD), with a legacy portfolio addressing allergies and fluoride deficiency. Aytu emphasizes patient access through its proprietary Aytu RxConnect support program.